Guggenheim Capital LLC Dynavax Technologies Corp Transaction History

Guggenheim Capital LLC

  • $14 Billion
  • Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Guggenheim Capital LLC holds 70,098 shares of DVAX stock, worth $900,058. This represents 0.01% of its overall portfolio holdings.

Number of Shares
70,098
Previous 65,852 6.45%
Holding current value
$900,058
Previous $739,000 5.55%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$10.05 - $11.61 $42,672 - $49,296
4,246 Added 6.45%
70,098 $780,000
Q2 2024

Aug 14, 2024
SELL
$10.73 - $12.58 $550,051 - $644,888
-51,263 Reduced 43.77%
65,852 $739,000
Q1 2024

May 14, 2024
BUY
$11.7 - $14.98 $9,149 - $11,714
782 Added 0.67%
117,115 $1.45 Million
Q4 2023

Feb 14, 2024
BUY
$13.09 - $14.98 $754,049 - $862,922
57,605 Added 98.09%
116,333 $1.63 Million
Q3 2023

Nov 14, 2023
BUY
$12.64 - $14.99 $86,369 - $102,426
6,833 Added 13.17%
58,728 $867,000
Q2 2023

Aug 11, 2023
BUY
$9.85 - $13.17 $357,200 - $477,596
36,264 Added 232.0%
51,895 $670,000
Q1 2023

May 10, 2023
SELL
$9.44 - $11.88 $103,094 - $129,741
-10,921 Reduced 41.13%
15,631 $153,000
Q4 2022

Feb 14, 2023
BUY
$10.27 - $13.29 $7,723 - $9,994
752 Added 2.91%
26,552 $282,000
Q3 2022

Nov 14, 2022
SELL
$9.93 - $17.44 $289,846 - $509,056
-29,189 Reduced 53.08%
25,800 $269,000
Q2 2022

Aug 15, 2022
BUY
$7.45 - $12.83 $409,668 - $705,508
54,989 New
54,989 $692,000
Q4 2018

Feb 14, 2019
SELL
$8.14 - $13.28 $1.13 Million - $1.84 Million
-138,719 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$11.85 - $16.0 $229,688 - $310,128
19,383 Added 16.24%
138,719 $1.72 Million
Q2 2018

Aug 14, 2018
BUY
$15.15 - $20.75 $106,928 - $146,453
7,058 Added 6.29%
119,336 $1.82 Million
Q1 2018

May 15, 2018
BUY
$14.65 - $19.9 $110,197 - $149,687
7,522 Added 7.18%
112,278 $2.23 Million
Q4 2017

Feb 14, 2018
SELL
$17.3 - $24.08 $74,095 - $103,134
-4,283 Reduced 3.93%
104,756 $1.96 Million
Q3 2017

Nov 14, 2017
BUY
$15.2 - $21.5 $1.66 Million - $2.34 Million
109,039
109,039 $2.35 Million

Others Institutions Holding DVAX

# of Institutions
275
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.62B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email